Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review
Journal of Cystic Fibrosis · 2023-03 · 22 (2) · 193-200
DOI: 10.1016/j.jcf.2022.08.008 ↗Kurz gefasst
Scoping Review in der Zeitschrift Journal of Cystic Fibrosis, 2023-03. Verfasst von Mitchell L Ramsey und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, OH, USA. Hauptthemen laut MEDLINE: Pancreas, Exocrine, Cystic Fibrosis, Pancreatitis, Exocrine Pancreatic Insufficiency. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Cystic fibrosis transmembrane conductance regulator (CFTR) modulators improve pulmonary outcomes in subjects with cystic fibrosis (CF); however, the effects on pancreatic manifestations are not well characterized. We hypothesized that CFTR modulators would improve measures of exocrine pancreatic function and outcomes. METHODS: We performed a systematic search to identify studies reporting measures of the exocrine pancreas in humans treated with CFTR modulators. Only studies reporting baseline and on-treatment assessments were included. RESULTS: Of 630 identified studies, 41 met inclusion criteria. CFTR modulators reduced acute pancreatitis events by 85% overall (rate ratio 0.15, 95% confidence interval (CI) 0.04, 0.52), with a greater effect seen in the subgroup with pancreas sufficient CF (PS-CF) (rate ratio 0.13 (95% CI 0.03, 0.53). Among 293 subjects with baseline and on-treatment evaluation of pancreas sufficiency, 253 were pancreas insufficient at baseline and 54 (21.3%) converted to pancreas sufficiency. Of 32 subjects with baseline FE-1 values
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
- Division of General Internal Medicine, The Ohio State University Wexner Medical Center, USA.
- Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University College of Medicine, USA.
- Pancreatitis Center, Division of Gastroenterology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
- Division of Pediatric Pulmonology and Sleep Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
- Division of Pulmonary and Critical Care Medicine, The Ohio State University Wexner Medical Center, USA.
Zitieren
APA
Ramsey, M. L., Li, S. S., Lara, L. F., Gokun, Y., Akshintala, V. S., Conwell, D. L., Heintz, J., Kirkby, S. E., McCoy, K. S., Papachristou, G. I., Patel, A., Singh, V. K., & Hart, P. A. (2023). Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. Journal of Cystic Fibrosis, 22(2), 193-200. https://doi.org/10.1016/j.jcf.2022.08.008
Vancouver
Ramsey ML, Li SS, Lara LF, Gokun Y, Akshintala VS, Conwell DL, et al. Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. Journal of Cystic Fibrosis. 2023;22(2):193-200. doi:10.1016/j.jcf.2022.08.008
BibTeX
@article{Ramsey2023,
author = {Ramsey, Mitchell L and Li, Susan S and Lara, Luis F and Gokun, Yevgeniya and Akshintala, Venkata S and Conwell, Darwin L and Heintz, John and Kirkby, Stephen E and McCoy, Karen S and Papachristou, Georgios I and Patel, Alpa and Singh, Vikesh K and Hart, Phil A},
title = {Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review},
journal = {Journal of Cystic Fibrosis},
year = {2023},
volume = {22},
number = {2},
pages = {193--200},
doi = {10.1016/j.jcf.2022.08.008}
}
EUVIMED